Literature DB >> 7022717

The immunopathology of acute type B hepatitis.

L Bianchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022717     DOI: 10.1007/bf01951491

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  101 in total

1.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

Review 2.  Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets.

Authors:  K H Meyer zum Büschenfelde; T H Hütteroth; W Arnold; U Hopf
Journal:  Prog Liver Dis       Date:  1979

3.  Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis.

Authors:  W D Reed; A L Eddleston; H Cullens; R Williams; A J Zuckerman; D K Peters; D G Williams; W A Maycock
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

4.  Subtypes of Australia antigen and hepatitis-B virus.

Authors:  G L Le Bouvier; R W McCollum; W J Hierholzer; G R Irwin; S Krugman; J P Giles
Journal:  JAMA       Date:  1972-11-20       Impact factor: 56.272

5.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

7.  Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.

Authors:  S N Huang
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

8.  Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBs Ag).

Authors:  G R Dreesman; F B Hollinger; J L Melnick
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

9.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

10.  Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis.

Authors:  P M Kaplan; J L Gerin; H J Alter
Journal:  Nature       Date:  1974-06-21       Impact factor: 49.962

View more
  5 in total

Review 1.  T cells causing immunological disease.

Authors:  R M Zinkernagel; H Pircher; P S Ohashi; H Hengartner
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluated.

Authors:  T Leist; A Althage; E Haenseler; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

Review 3.  Neutralizing antiviral antibody responses.

Authors:  R M Zinkernagel; A LaMarre; A Ciurea; L Hunziker; A F Ochsenbein; K D McCoy; T Fehr; M F Bachmann; U Kalinke; H Hengartner
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

Review 4.  Liver lesions in hepatitis B viral infection.

Authors:  V J Desmet
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb

5.  T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

Authors:  R M Zinkernagel; E Haenseler; T Leist; A Cerny; H Hengartner; A Althage
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.